SetPoint Medical

OverviewSuggest Edit

SetPoint Medical is a biomedical technology company developing neuromodulation therapies for patients with inflammatory autoimmune diseases, such as rheumatoid arthritis and Crohn's Disease. 
The company's scientific platform is based on the Inflammatory Reflex—the natural mechanism by which the central nervous system regulates the immune system. SetPoint's approach uses vagus nerve stimulation to activate the Inflammatory Reflex, which published literature suggests produces a potent systemic anti-inflammatory effect. The Company's novel platform consists of an implantable miniature neuromodulation device, wireless charger, and iPad control application. 
TypePrivate
Founded2006
HQSanta Clarita, CA, US
Websitesetpointmedical.com
Employee Ratings3.9
Overall CultureA

Latest Updates

Employees (est.) (Apr 2022)57(-1%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at SetPoint Medical

Murthy Simhambhatla

Murthy Simhambhatla

CEO
David Chernoff

David Chernoff

Chief Medical Officer
Bill Calle

Bill Calle

VP of Product Development
Lusin Markaryan

Lusin Markaryan

VP of Regulatory Affairs
Ankit Shah

Ankit Shah

Senior Director of Commercialization and Marketing
Kevin Wilkin

Kevin Wilkin

Director of Quality
Show more

SetPoint Medical Office Locations

SetPoint Medical has an office in Santa Clarita
Santa Clarita, CA, US (HQ)
25101 Rye Canyon Loop
Show all (1)

SetPoint Medical Financials and Metrics

Summary Metrics

Founding Date

2006

SetPoint Medical total Funding

$84.3 m

SetPoint Medical latest funding size

$30 m

Time since last funding

5 years ago

SetPoint Medical investors

SetPoint Medical's latest funding round in August 2017 was reported to be $30 m. In total, SetPoint Medical has raised $84.3 m
Show all financial metrics

SetPoint Medical Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

SetPoint Medical Online and Social Media Presence

Embed Graph

SetPoint Medical Company Culture

  • Overall Culture

    A

    90/100

  • CEO Rating

    A+

    90/100

  • Compensation

    A+

    100/100

Learn more on Comparably

SetPoint Medical News and Updates

SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs

Accomplished leader will advance SetPoint's clinical program in rheumatoid arthritis Accomplished leader will advance SetPoint's clinical program in rheumatoid arthritis

Runway Growth Capital Announces a Senior Secured Term Loan of $35 Million to SetPoint Medical

WOODSIDE, Calif., July 13, 2021 /PRNewswire/ -- Runway Growth Capital LLC ("Runway"), a leading provider of growth loans to both venture and non-venture backed companies seeking an alternative to raising equity, today announced the close of a senior secured term loan of $35 million to...

SetPoint Medical CEO Murthy Simhambhatla Named to AIMBE College of Fellows

VALENCIA, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that the American Institute for Biological and Medical Engineering (AIMBE) has elected Murthy Simhambhatla, PhD…

SetPoint Medical Announces First Patient Enrolled in the RESET-RA Study

Pivotal IDE Study will evalute SetPoint’s propriertary bioelectronic device for treatment of Rheumatoid Arthritis Pivotal IDE Study will evalute SetPoint’s propriertary bioelectronic device for treatment of Rheumatoid Arthritis

SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform

VALENCIA, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- SetPoint Medical Corporation today announced raising $64M in a Preferred Stock Financing to support its RESET-RA pivotal trial in patients with rheumatoid arthritis (RA). The company is developing its platform for the treatment of chronic, inflam…

SetPoint Medical Receives FDA Breakthrough Device Designation for its Novel Bioelectronic Platform

VALENCIA, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- SetPoint Medical, Inc. today announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the use of its novel bioelectronic device for patients with rheumatoid arthritis (RA) who have incomp…
Show more

SetPoint Medical Blogs

Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study

The inflammatory reflex plays a role in regulating innate and adaptive immunity by modulating cellular and molecular inflammatory pathways. The vagus nerve is a major constituent of the inflammatory reflex and studies have shown that the reflex can be activated by electrical stimulation of the vagus…

New technology could signal the future of medicine

ABC News’ Will Carr reports on new, cutting-edge bioelectronic medicine that holds promise for treating diseases like Crohn’s and Parkinson’s. The post New technology could signal the future of medicine appeared first on SetPoint Medical.

SetPoint Medical Appoints Murthy Simhambhatla as President and Chief Executive Officer

  Industry veteran brings biopharma and medical device company leadership experience as SetPoint advances its proprietary bioelectronic medicine platform Valencia, CA – August 13, 2018 – SetPoint Medical, a clinical-stage company developing bioelectronic therapy for chronic inflammatory diseases, an…

SetPoint Medical Reports Positive Long-term Results from its Clinical Study of Bioelectronic Medicine to Treat Rheumatoid Arthritis

  Results presented at Annual European Congress of Rheumatology highlight strong therapy adherence and significant reduction in rheumatoid arthritis symptoms after 24-months of therapy Valencia, CA – June 19, 2018 – SetPoint Medical, a clinical-stage biomedical technology company developing bioelect…

SetPoint Medical Presents Positive Data from its Clinical Study of Bioelectronic Medicine for Treatment of Crohn’s Disease

  Proof-of-Concept Data Presented at Digestive Disease Week in Washington D.C. Valencia, CA  – June 11, 2018 – SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced the presentation of positive clinical results …

SetPoint Medical Frequently Asked Questions

  • When was SetPoint Medical founded?

    SetPoint Medical was founded in 2006.

  • Who are SetPoint Medical key executives?

    SetPoint Medical's key executives are Murthy Simhambhatla, David Chernoff and Bill Calle.

  • How many employees does SetPoint Medical have?

    SetPoint Medical has 57 employees.

  • Who are SetPoint Medical competitors?

    Competitors of SetPoint Medical include Tivic Health, Inspire Medical Systems and Restorative Therapies.

  • Where is SetPoint Medical headquarters?

    SetPoint Medical headquarters is located at 25101 Rye Canyon Loop, Santa Clarita.

  • Where are SetPoint Medical offices?

    SetPoint Medical has an office in Santa Clarita.

  • How many offices does SetPoint Medical have?

    SetPoint Medical has 1 office.